Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Josef Kroupa et al., published in The New England Journal of Medicine, adding:
“Local administration with catheter is reasonable for drugs such as fibrinolytic agents. Simple streptokinase or urokinase looks more effective than complicated t-PA…”
Title: Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
Authors: Josef Kroupa, Martin Radvan, Jan Mrozek, Martin Sluka, Stepan Jirous, Ota Hlinomaz, Milan Pliva, Jan Pudil, Hana Voberkova, Martin Kozel, Martin Poloczek, Martin Kamenik, Michal Brabec, Eva Lichnerova, Martin Hutyra, Ivo Bernat, Martin Novak, Petr Tousek, Viktor Kocka.
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD